Drug Shortage Report for FIASP

Last updated on 2025-07-31 History
Report ID 260746
Drug Identification Number 02460408
Brand name FIASP
Common or Proper name FIASP®
Company Name NOVO NORDISK CANADA INC
Market Status MARKETED
Active Ingredient(s) INSULIN ASPART
Strength(s) 100UNIT
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size EA
ATC code A10AB
ATC description INSULINS AND ANALOGUES
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2025-06-20
Estimated end date 2025-08-04
Actual end date 2025-07-30
Shortage status Resolved
Updated date 2025-07-31
Company comments Manufacturing issues preventing production/release. Alternate products available: NovoRapid® Vials, Fiasp® FlexTouch®
Health Canada comments
Tier 3 Status No
Contact Address 101-2476 ARGENTIA ROAD
MISSISSAUGA, ONTARIO
CANADA L5N 6M1
Company contact information 1 800 465 4334

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2025-07-31 English Compare
v11 2025-07-30 French Compare
v10 2025-07-30 English Compare
v9 2025-07-30 English Compare
v8 2025-07-15 French Compare
v7 2025-07-15 English Compare
v6 2025-06-21 English Compare
v5 2025-06-20 French Compare
v4 2025-06-20 French Compare
v3 2025-06-20 English Compare
v2 2025-06-20 French Compare
v1 2025-06-20 English Compare

Showing 1 to 12 of 12